All In Biotech

Drug Trial Radar · NCT00259766

SHARE - Symbicort and Health Economics in a Real Life Evaluation

Symbicort and Health Economics in a Real Life Evaluation - SHARE - A Randomised, Open-Label, Parallel-Group, Multicentre Study to Assess the Asthma-Related Health-Care Costs, in Ordinary Clinical Practice During 12 Months

Last checked: Nov 20, 2026Latest source record: Jan 24, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,970 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,970

Actual

Start

Apr 2004

Primary completion

Not stated

Study completion May 2007

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Dec 1, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare health-related costs and asthma control in ordinary clinical practice during 12 months for Symbicort® given as a low maintenance dose plus as needed compared to a free combination of Pulmicortâ and Oxis® plus Bricanyl® as needed, and Symbicort fixed dosing plus Bricanyl as needed in asthmatic patients not adequately controlled on inhaled glucocorticosteroids alone.

Conditions

  • Asthma

Interventions

  • BudesonideDrug

  • FormoterolDrug

  • TerbutalineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Asthma-related health-care utilization as measured by total amount of asthma medication purchased and number of contacts with health-care facilities

Locations

108 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Åkersberga, Sweden

  • Research Site

    Alingsås, Sweden

  • Research Site

    Ånge, Sweden

  • Research Site

    Ängelholm, Sweden

  • Research Site

    Angered, Sweden

  • Research Site

    Arlöv, Sweden

  • Research Site

    Årsta, Sweden

  • Research Site

    Arvidsjaur, Sweden

  • Research Site

    Arvika, Sweden

  • Research Site

    Åstorp, Sweden

  • Research Site

    Åtvidaberg, Sweden

  • Research Site

    Bandhagen, Sweden

  • Research Site

    Boden, Sweden

  • Research Site

    Borensberg, Sweden

  • Research Site

    Bro, Sweden

  • Research Site

    Brunflo, Sweden

  • Research Site

    Eskilstuna, Sweden

  • Research Site

    Falun, Sweden

  • Research Site

    Filipstad, Sweden

  • Research Site

    Fränsta, Sweden

  • Research Site

    Gagnef, Sweden

  • Research Site

    Gärsnäs, Sweden

  • Research Site

    Gothenburg, Sweden

  • Research Site

    Grängesberg, Sweden

  • Research Site

    Gullspång, Sweden

  • Research Site

    Håby, Sweden

  • Research Site

    Halmstad, Sweden

  • Research Site

    Helsingborg, Sweden

  • Research Site

    Hisingsbacka, Sweden

  • Research Site

    Hofors, Sweden

  • Research Site

    Höganäs, Sweden

  • Research Site

    Höllviken, Sweden

  • Research Site

    Huddinge, Sweden

  • Research Site

    Iggesund, Sweden

  • Research Site

    Jarfalla, Sweden

  • Research Site

    Kalmar, Sweden

  • Research site

    Karlskoga, Sweden

  • Research Site

    Karlstad, Sweden

  • Research Site

    Katrineholm, Sweden

  • Research Site

    Kil, Sweden

Showing 40 of 108 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.